Market Size | A Fast-Growing Opportunity:
The peptide opportunity is expanding rapidly, led by GLP-1 drugs and a growing clinical pipeline.
🔸Peptide therapeutics: ~$141 Bn in 2025 → $295 Bn by 2033
🔸Peptide API market: ~$6 Bn in 2025 → $14 Bn by 2030
🔸Around 800 peptide molecules are under development globally
The bigger opportunity for Indian companies lies in APIs, CDMO manufacturing, protected amino acids, purification and fill-finish.
September 3, 2026 1.4K 9
